Preventing OHSS by inducing oocyte maturation with GnRH agonist, instead of HCG, in high responders treated with GnRH antagonist protocols for IVF: a comparison between single dose (3 mg) and daily dose (0.25 mg) regimens

被引：0

作者：

Bar-Hava, I. ^{[1
]}

Rabinson, J. ^{[1
]}

Ben-Mordechay, R. ^{[1
]}

Segal, S. ^{[1
]}

Tur-Kaspa, I. ^{[1
]}

机构：

[1] Barzilai Govt Hosp, IVF Unit, Obstet & Gynecol Dep, Ashqelon, Israel

来源：

HUMAN REPRODUCTION | 2003年 / 18卷

关键词：

D O I：

暂无

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

引用

页码：132 / 132

页数：1

共 10 条

[1] IVF outcome in poor responders: Comparison of high-dose gonadotrophin therapy with adjuvant therapy using a GnRH antagonist or a GnRH agonist
Singleton, SD
Oehninger, S
Stadtmauer, L
Gibbons, W
Mayer, J
FERTILITY AND STERILITY, 2004, 82 : S240 - S240
[2] THE EFFECTS OF GnRH ANTAGONIST SINGLE DOSE (0.25MG) ON THE PREVENTION OF OVARIAN HYPERSTIMULATION SYNDROME (OHSS) IN PATIENTS WITH HIGH E2 LEVELS BY COH IN A STANDARD GnRH AGONIST LONG PROTOCOL.
Kim, Y. Y.
Jung, Y. H.
Kim, M. H.
Cho, J. D.
FERTILITY AND STERILITY, 2010, 94 (04) : S166 - S166
[3] The use of a GnRH antagonist (Cetrorelix®) in a single dose protocol in IVF-embryo transfer:: a dose finding study of 3 versus 2 mg
Olivennes, F
Alvarez, S
Bouchard, P
Fanchin, R
Salat-Baroux, J
Frydman, R
HUMAN REPRODUCTION, 1998, 13 (09) : 2411 - 2414
[4] The use of a GnRH antagonist (Cetrorelix) in a single-dose protocol in IVF-embryo transfer: a dose-finding study of 3 versus 2 mg
Olivennes, F
Alvarez, S
Bouchard, P
Fanchin, R
Salat-Baroux, J
Frydman, R
HUMAN REPRODUCTION, 1998, 13 : 69 - 69
[5] GnRH agonist long protocol vs. a single 3-mg GnRH antagonist - A comparison of 2 protocols for pituitary down-regulation in oocyte donor-controlled ovarian hyperstimulation cycles
Erb, Teresa M.
Wakim, Anthony N. G.
JOURNAL OF REPRODUCTIVE MEDICINE, 2008, 53 (05) : 331 - 337
[6] DOES GNRH AGONIST TRIGGER FOR HIGH RESPONDERS DURING IVF/ICSI CYCLES IMPROVE THE NUMBER OF GOOD-QUALITY EMBRYOS, THE INCIDENCE OF MODERATE-TO-SEVERE OHSS, AND PREGNANCY OUTCOME COMPARED TO GNRH-A PLUS LOW-DOSE HCG?.
Li, Ya
FERTILITY AND STERILITY, 2021, 116 (03) : E370 - E371
[7] A single dose new long-acting GnRH-antagonist Degarelix effectively downregulates LH in stimulated IVF cycles triggered with agonist for oocyte maturation. A proof of concept study
Papanikolaou, E.
Kyrou, D.
Kotanidis, L.
Katsoula, E.
Timotheou, E.
Tatsi, P.
Zafeiratis, O.
Najdecki, R.
HUMAN REPRODUCTION, 2016, 31 : 437 - 437
[8] Results of two, large multicentre, multinational, phase IIIb studies using the single (3 mg) or the multiple dose (0.25 mg) protocol of the GnRH antagonist cetrorelix (Cetrotide) to prevent the premature LH surge during assisted reproductive techniques
Olivennes, F.
Frydman, R.
Diedrich, K.
Felberbaum, R.
HUMAN REPRODUCTION, 2003, 18 : 49 - 50
[9] LH-control with an GnRH-antagonist Cetrotide® 3 mg in a single dose protocol:: Open, prospective non-randomised study in 100 patients treated in superovulation cycles
Hübner, S
Mittmann, S
Moltrecht, R
GEBURTSHILFE UND FRAUENHEILKUNDE, 2001, 61 (01) : 31 - 34
[10] Comparison of follicular fluid IGF-I, IGF-II, IGFBP-3 and IGFBP-4 concentrations and their ratios between GnRH agonist long protocol and GnRH antagonist multiple-dose protocol for controlled ovarian hyperstimulation (COH) in in vitro fertilization and embryo transfer (IVF-ET).
Choi, Y
Jee, B
Ku, S
Suh, C
Moon, S
Kim, S
FERTILITY AND STERILITY, 2005, 84 : S316 - S317

← 1 →